RxDoctor Payments Data

Randall Minion

Addiction Medicine · Fort Dodge, IANPI 1003887431

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.9% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations.

$1,963in general payments, 2019–2025

Across 143 payments — averaging $13.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$238
  • Astellas Pharma US Inc$215
  • GSK$215
  • AstraZeneca$210
  • Amgen$179
  • Boehringer Ingelheim$140
  • plus $767 from 14 others

What the payments were for

  • Food & beverage$1,84494%
  • Education$1196%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few addiction medicine providers in Iowato place this figure against a meaningful peer group, so we don't.

Other addiction medicine in Fort Dodge

Where these figures come from

Is this you, or does something look wrong? →